Valuation: Embecta Corp.

Market Cap 355M 316M 293M 266M 503M 33.72B 511M 3.52B 1.38B 17.59B 1.33B 1.3B 56.09B P/E 2026 *
5.3x
P/E 2027 * 4.54x
Enterprise Value 355M 316M 293M 266M 503M 33.72B 511M 3.52B 1.38B 17.59B 1.33B 1.3B 56.09B EV / Sales 2026 *
0.35x
EV / Sales 2027 * 0.33x
Free-Float
97.99%
Yield 2026 *
4.02%
Yield 2027 * 0.65%
1 day-2.79%
1 week+10.29%
Current month+10.78%
1 month+22.22%
3 months+87.16%
6 months-34.07%
Current year-47.22%
1 week 5.77
Extreme 5.77
6.58
1 month 5.09
Extreme 5.09
6.58
Current year 2.77
Extreme 2.77
13.44
1 year 2.77
Extreme 2.77
14.91
3 years 2.77
Extreme 2.77
21.48
5 years 0
Extreme 0
49
10 years 0
Extreme 0
49
Manager TitleAgeSince
Chief Executive Officer 58 2022-03-21
Director of Finance/CFO 53 2022-03-21
Investor Relations Contact - 2022-05-31
Director TitleAgeSince
Chairman 58 2026-02-10
Director/Board Member 60 2022-03-19
Director/Board Member 58 2022-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Sell

Director

-6,293 0.0111%
8/12/26 Buy

General Counsel

20,000 0.0337%
8/12/26 Buy

Chief Financial Officer

20,000 0.0337%
Change 5-day change 1-year change 3-year change Capi.($)
-2.79%+10.29%-54.20%-60.34% 355M
+0.20%+5.31%-17.82%+13.79% 181B
-0.73%+7.09%-0.31%+32.06% 116B
+0.49%+6.25%-20.20%+11.58% 113B
+3.83%+5.50%-44.18%-6.77% 79.83B
-0.14%+5.27%+6.74%+82.45% 65.06B
+2.79%+2.37%+15.93%+68.64% 54.35B
-1.04%+4.35%+3.50%-26.18% 52.23B
+2.41%+8.18%-12.08%+30.45% 44.15B
-1.90%+2.29%+29.72%+8.98% 32.47B
Average +0.39%+5.79%-9.29%+15.46% 73.89B
Weighted average by Cap. +0.62%+5.59%-9.72%+22.10%

Financials

2026 *2027 *
Net sales 1.02B 911M 844M 768M 1.45B 97.23B 1.47B 10.15B 3.98B 50.74B 3.84B 3.76B 162B 1.08B 962M 891M 811M 1.53B 103B 1.55B 10.71B 4.2B 53.58B 4.06B 3.97B 171B
Net income 69.3M 61.6M 57.1M 51.95M 98.03M 6.58B 99.6M 686M 269M 3.43B 260M 255M 10.94B 76.83M 68.3M 63.3M 57.59M 109M 7.29B 110M 761M 298M 3.81B 288M 282M 12.13B
Net Debt - -
Projected Income Statement - Annual - Embecta Corp.
Logo Embecta Corp.
Embecta Corp. is a global medical device company. It provides solutions to improve the health and well-being of people living with diabetes. Its portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through channels, including retail, hospitals and pharmacies. It is also a manufacturer of medical devices and drug delivery technologies.
Employees
1,850
Date Price Change Volume
26-10-16 US$6.270 -2.79% 622,681
26-10-15 US$6.450 +4.37% 983,709
26-10-14 US$6.180 -0.32% 651,477
26-10-13 US$6.200 +3.51% 732,864
26-10-12 US$5.990 +5.36% 1,053,590
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Embecta Corp.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
6.270USD
Average target price
4.000USD
Spread / Average Target
-36.20%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Embecta Corp.
  1. Stock Market
  2. Stocks
  3. EMBC Stock